C-reactive protein probably can't predict chorioamnionitis

Article

S

No clear evidence exists to support the use of C-reactive protein (CRP) for the early diagnosis of chorioamnionitis following preterm prelabor rupture of membranes, according to a systematic review from the United Kingdom.

Researchers reviewed eight studies including 610 cases and found wide variation in the results. Three of the studies concluded that CRP was diagnostically useful, although one suggested using a higher CRP threshold (30, 35, or 40 mg/L for single estimations or >20 mg/L for serial estimations), while the remaining studies concluded that CRP as a diagnostic tool for chorioamnionitis was poor.

Part of the problem is the disagreement about what CRP values are normal during pregnancy and whether concentrations should increase as pregnancy progresses. While the use of serial measurements of CRP seems promising, it requires further investigation.

Recent Videos
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
How AI is revolutionizing breast cancer detection | Image Credit: simonmed.com
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Christie Hilton, DO, discusses breast cancer management | Image Credit: findcare.ahn.org
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
Sheryl Kingsberg, PhD: Psychedelic RE104 for postpartum depression
Mammograms may reveal hidden cardiovascular risks, study finds | Image Credit: providers.ucsd.edu
Erika Hamilton highlights emerging breast cancer trends and advances in treatment | Image Credit: sarahcannon.com
© 2024 MJH Life Sciences

All rights reserved.